Results for tag: "Minimal Residual Disease Drug"

Minimal Residual Disease (MRD) drugs are a type of hematological drug used to treat blood cancers such as leukemia and lymphoma. MRD drugs are used to reduce the number of cancer cells in the body, and to prevent the cancer from returning. These drugs are typically used in combination with other treatments such as chemotherapy and radiation therapy. MRD drugs work by targeting specific cancer cells and destroying them, while leaving healthy cells unharmed. MRD drugs are an important part of the treatment of blood cancers, as they can help reduce the risk of relapse and improve the chances of long-term survival. They are also used to monitor the progress of the disease and to detect any recurrence of the cancer. Some companies in the MRD drug market include Novartis, Celgene, and Gilead Sciences. These companies are involved in the research, development, and manufacture of MRD drugs. Other companies such as Amgen, Merck, and Pfizer are also involved in the development and marketing of MRD drugs. Show Less Read more